Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cash from Investing Activities

Akebia Therapeutics Cash from Investing Activities Chart (AKBA)

Akebia Therapeutics annual/quarterly Cash from Investing Activities from 2012 to 2020.
  • Akebia Therapeutics Cash from Investing Activities for the quarter ending June 06, 2020 was $-50m a 148.78% decrease of -74m year over year
  • Akebia Therapeutics Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-3m a 6,775.75% decrease of -209m year over year
  • Akebia Therapeutics Annual Cash from Investing Activities for 2019 was $211m a 82.67% increase of 175m from 2018
  • Akebia Therapeutics Annual Cash from Investing Activities for 2018 was $37m a 584.40% increase of 214m from 2017
  • Akebia Therapeutics Annual Cash from Investing Activities for 2017 was $-177m a 107.17% decrease of -190m from 2016
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Cash from Investing Activities Data

06/2020$-50m
03/2020$0m
12/2019$22m
09/2019$24m
06/2019$54m
03/2019$110m
12/2018$17m
09/2018$11m
06/2018$-4m
03/2018$12m

Annual AKBA Cash from Investing Activities Data

2019$211m
2018$37m
2017$-177m
2016$13m
2015$-14m
2014$-65m
2013$-11m
2012$1m
2011$-1m